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Lung disease is the fourth leading cause of 
morbidity and mortality in the U.S. popula-
tion. Although death rates from heart dis-
ease, cancer, and cerebro  vascular disease have 
decreased in the past 10 years, death rates 
from chronic lower respiratory disease have 
not. Although tobacco use and traffic-related 
pollutants account for a portion of disease 
statistics, the precise etiology of lung disease 
remains unknown. A significant problem 
in assessing the contribution of individual 
chemicals or mixtures of chemicals to lung 
disease is related to the uncertainty of the use 
of animal models for human lung disease. 
Numerous chemicals, including naphtha-
lene (Plopper et al. 1992), trichloro  ethylene 
(Odum et al. 1992), and styrene (Green et al. 
2001), cause differential toxicity in two com-
mon rodent models, mice and rats, raising the 
question of relevance of these rodent models 
for human risk assessment.
Naphthalene administration results in 
highly selective necrosis of nonciliated bron-
chiolar epithelial cells of mice regardless of 
the route of administration. Inhaled concen-
trations of 2–5 ppm for 4 hr, well below the 
current occupational standard, cause detect-
able toxicity (West et al. 2001). In contrast, 
injury to airway epithelium of the rat does 
not occur at concentrations ≤ 100 ppm (West 
et al. 2001). The nasal epithelium of both rats 
and mice is highly sensitive to naphthalene 
administered either parenterally or by inhala-
tion (Lee et al. 2005; Plopper et al. 1992). 
Recent studies have demon  strated sensitiv-
ity of rat olfactory epithelium at concentra-
tions similar to those in urban atmospheres 
(0.3 ppm) (Dodd et al. 2010).
The species-, tissue-, and site-selective 
injury caused by naphthalene has been used 
to identify mechanisms associated with tox-
icity (for review, see Buckpitt et al. 2002). 
Naphthalene under  goes metabolism by the 
cytochrome P450 mono  oxygenases to reactive 
metabolites that become bound covalently to 
tissue proteins. The primary P450 involved 
in metabolism in the mouse lung and rat nose 
appears to be cytochrome P450 2F (CYP2F); 
this protein has high affinity for naphthalene 
as a substrate (Km, ~ 4 µM) with high cata-
lytic turnover (104/min) (Shultz et al. 1999). 
CYP2F orthologs found in the lungs of non-
human primates (CYP2F5; Baldwin et al. 
2005) and humans (CYP2F1; Nhamburo 
et al. 1990) had little or no catalytic activ-
ity when expressed as recombinant enzyme 
(Lanza et al. 1999). This was consistent with 
the finding that lung microsomes from mon-
keys and humans metabolized naphthalene 
to water-soluble metabolites at very low rates 
(Buckpitt and Bahnson 1986; Buckpitt et al. 
1992) and that dissected monkey airways gen-
erated metabolites very slowly (Boland et al. 
2004). Because the initial step in the turnover 
of naphthalene is critical to toxicity, these data 
would indicate that monkeys and humans 
would be considerably less susceptible to 
naphthalene exposure than rodents. However, 
more recent data have shown that, although 
the rates of water-soluble metabolite forma-
tion are low, reactive metabolite protein bind-
ing occurs at similar levels in sensitive rodent 
tissues (Cho et al. 1994) and in dissected air-
ways of monkeys (Boland et al. 2004).
Human exposure to naphthalene is 
nearly universal; the recent National Health 
and Nutrition Examination Survey studies 
demon  strated detectable levels of 1-naphthol 
glucuronide in the urine of all 2,785 sub-
jects tested (Li et al. 2008). However, epi-
demiologic studies have failed to establish a 
relationship between naphthalene exposure 
and any long-term health consequences in 
the respiratory tract. Either humans are not 
as susceptible to the compound as rodents 
are, or respiratory diseases are multi  factorial 
in origin and epidemiologic studies have not 
been sufficiently powered to detect subtle 
contributions of naphthalene to the overall 
incidence of disease.
In the present study we focused on pro-
tein-bound metabolites in nasal epithelium of 
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rats and rhesus macaques. In contrast to pre-
vious work showing 10- to 100-fold higher 
rates of naphthalene metabolism by dissected 
mouse airways compared with the rhesus air-
way (Boland et al. 2004; Plopper et al. 1991), 
the present study shows that the rates of for-
mation of covalently bound metabolites in 
rhesus nasal epithelium are similar to those in 
rat nasal epithelium, a target for naphthalene 
toxicity. This study also demon  strates some 
concordance in the adducted proteins identi-
fied in rat and monkey nasal epithelial incu-
bations. We identified proteins involved in 
the unfolded protein response in incubations 
with rat but not monkey nasal epithelium. 
Proteins identified in the present work could 
serve as potential biomarker targets for studies 
in exposed human populations.
Materials and Methods
Animals. All animal work was conducted 
under protocols approved by the University 
of California–Davis (UCD) Animal Use 
and Care Committee. Animals were treated 
humanely and with regard to alleviation 
of suffering. Male Sprague-Dawley rats   
(200–225 g body weight) were obtained from 
Harlan Laboratories (Indianapolis, IN) and 
housed in the UCD vivarium for at least 
1 week before experimentation. Animals 
were euthanized with an overdose of pento-
barbital, and olfactory and septal turbinates 
were removed. Ethmoturbinates and maxillo-
turbinates were obtained from eight male 
and seven female rhesus macaques through 
the California National Primate Research 
Center [animal charac  teris  tics are available in 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901333)]. All rhesus macaque tissue was 
from animals euthanized for normal colony 
maintenance at the center.
Reagents. We obtained [1,4,5,8-14C]
naphthalene (specific activity 58 mCi/mmol) 
from Moravek Radiochemicals (Brea, CA) and 
checked purity (99%) by high-performance 
liquid chromatography. Protease inhibitor 
cocktail III, non  detergent sulfobetaine-195 
(NDSB-195), benzamidine, 1,10-phenan-
throline, aprotinin, pepstatin, and leupeptin 
were purchased from Calbiochem (La Jolla, 
CA). Rhinohide acrylamide/bisacrylamide was 
from Invitrogen (Carlsbad, CA), and Bio-Rad 
Protein Assay solution was purchased from 
Bio-Rad (Hercules, CA). We obtained immo-
bilized pH gradient (IPG) buffers and narrow-
range IPG Immobiline dry strips (18 cm) from 
GE Health Care (Piscataway, NJ). Unless 
other  wise stated, all reagents were molecular 
biology grade or better.
Tissue incubation and preparation. Tissue 
was incubated in oxygenated Waymouth’s 
medium deficient in sulfur amino acids 
(glutathione, cysteine, methio  nine) con-
taining 250 µM naphthalene or 250 µM 
14C-naphthalene at a specific activity of 
1.10 × 105 disintegrations per minute per 
nanomole. Incubations were performed for 
2 hr at 37°C in a shaking water bath. For pro-
tein identification, we incubated tissue with 
unlabeled substrate. 
After the incubation, tissues were rinsed 
with cold 5% dextrose and homogenized 
in lysis solution [2 M thiourea, 7 M urea, 
4% wt/wt 3-(3-cholamidopropyl)-dimethyl-
ammonio  propane sulfonate (CHAPS), 0.5% 
Triton X-100, 1% dithiothreitol, and 2% 
protease inhibitor cocktail] using glass–glass 
homogenizers. Tissues were allowed to sit 
at room temperature for 1 hr after homog-
enization to allow further solubilization and   
denaturation of proteins. Insoluble proteins 
were removed by centrifugation (100,000 × g 
for 1 hr).
The tough, bony structure of primate tur-
binates dictated the use of modified procedures 
for protein recovery. Briefly, after the incuba-
tion, the incubation medium was transferred to 
a clean centrifuge tube. The tissue was washed 
with 5% dextrose to remove buffer salts, and 
fractions of the aqueous phase were combined. 
These samples were centrifuged to recover any 
tissue/cells removed, and the pellets were com-
bined with the remaining cartilage containing 
the epithelium. Lysis buffer containing protease 
inhibitors was added, and the tube was agitated 
on a rotating shaker to dislodge cells.
Comparison of covalent binding levels. A 
portion (~ 1 mg protein) of each sample (from 
rat or monkey nasal epithelium) incubated 
with 14C-naphthalene was dialyzed in 0.1% 
sodium dodecyl sulfate, 1 mM disodium 
EDTA at 4°C [3,500 molecular weight (MW) 
cutoff Slide-A-Lyzers; Pierce, Rockford, IL]. 
The dialysis solution was replaced with fresh 
solution until the counts per minute was less 
than twice the background level. Finally, we 
determined the specific activity of adducted 
protein for each sample by scintillation count-
ing and a protein assay (Bradford 1976).
Separation and identification of adducted 
protein. Procedures for the separation, 
localiza  tion, and identification of adducted 
proteins have been described in detail previ-
ously (Lin et al. 2005). Briefly, samples were 
not pooled, and separate gels were run for 
each incubation with labeled (for imaging) 
and unlabeled (for identification) naphthalene. 
Proteins were resolved by two-dimensional 
(2D) gel electro  phoresis on 18-cm narrow-
range pI (iso  electric point) strips for 4.5–5.5 
and 5.5–6.7 pI. Strips were rehydrated with 
300 µg protein for rat samples or 600 µg 
protein for monkey samples. Gels contain-
ing non  radioactive samples were silver stained 
and imaged on a 16-bit gray-scale scanner. 
14C-Labeled sample gels were electro  blotted to 
Sequi-Blot polyvinylidene fluoride membrane 
(0.2 µm; Bio-Rad), and these were placed 
against storage phosphor screens for 60 days. 
The patterns of 14C-labeled adducted proteins 
on the 2D gels were visualized using the GE 
Typhoon imager (GE Health Care). After 
excising protein spots of interest from non-
radioactive gels, the gel plugs were destained, 
washed, and incubated in 1:1 (vol/vol) aceto-
nitrile:50 mM ammonium bicarbonate fol-
lowed by 100% acetonitrile. Tryptic digestion 
and matrix-assisted laser desorption ionization 
(MALDI) tandem mass spectroscopy (MS/
MS) identification was carried out as described 
by Lin et al. (2006). 
We used GPS Explorer Workstation soft-
ware (version 3.5; Applied Biosystems, Foster 
City, CA) and MASCOT (Matrix Sciences, 
Boston, MA) to search protein databases in 
the International Protein Index (IPI) rat data-
base (http://www.ebi.ac.uk/IPI/), the National 
Center for Biotechnology Information pri-
mate database (NCBI; http://www.ncbi.nlm.
nih.gov/), and the UniProt database (http://
www.ebi.ac.uk/uniprot/). Databases were 
searched for a precursor tolerance of 150 ppm, 
MS/MS fragment tolerance of 0.2 Da, a 
maxi  mum of two missed cleavages, and vari-
able modifications for carbamido  methylation 
and methionine oxidation. An identification 
with a probability-based MOWSE score > 60, 
obtained through MASCOT, was considered 
statistically significant (p < 0.05). 
Results
The specific activities of adducted proteins 
(nanomoles bound per milligram protein) 
generated in in vitro incubations of nasal epi-
thelium from rats or rhesus macaques varied 
from 1.0 to 1.5 nmol/mg protein; we noted 
no statistically significant difference in the data 
obtained from rat olfactory and septal epithe-
lium compared with rhesus ethmo  turbinates 
and maxillo  turbinates (Figure 1). Compared 
with incubations of target airway subcompart-
ments (minor daughter and distal airway) from 
the mouse (Cho et al. 1994), the overall levels 
of adduct generated in vitro are slightly lower 
in rat and monkey nasal epithelial mucosal 
incubations.
Representative images from the phosphor-
imaging screens and complementary silver-
stained gels/phosphor images indicating the 
spot locations chosen for MALDI dual time 
of flight (TOF/TOF) MS analysis are avail-
able in Supplemental Material, Figures 1 
and 2 (doi:10.1289/ehp.0901333). In general, 
more adducts were apparent on the images 
from incubations of rat nasal epithelium than 
on those from rhesus macaques, but the pat-
terns of major adducts were similar. Spots 
were matched using the alignment function 
of Progenesis SameSpots and Progenesis 
PG220 (version 2006; Nonlinear Dynamics, 
Durham, NC) matches were manually veri-
fied. For identification, we used only those Reactive naphthalene metabolites in nasal tissue
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features that could be aligned with the storage 
phosphor images and selected from the gel 
with high confidence. 
We identified a large number of adducted 
proteins after incubation of rat nasal olfac-
tory epithelium with naphthalene (Table 1). 
These included a number of redundant iden-
tifications of structural proteins (actin and 
tubulin), catalytic proteins (some of which are 
involved in energy metabolism such as ATP 
synthase), and a number of proteins involved 
in the unfolded protein response, including 
one of the master regulators of that response, 
glucose regulated protein (heat shock 70 kDa 
protein 5). In contrast, fewer features were 
identified from the gels of monkey ethmo-
turbinates, representing only three non-
redundant proteins (Table 2). Two of these 
were structural proteins (actin and tubulin), 
and the third was a protease inhibitor with a 
myriad of functions.
Discussion
The chronic bioassays conducted by the 
National Toxicology Program on the poten-
tial carcinogenicity of naphthalene in mice 
(Abdo et al. 1992) and rats (Abdo et al. 2001) 
have raised concerns about the possible effects 
of this compound on human health. In mice, 
an increased incidence of bronchiolo  alveolar 
adenoma was observed in females at the high-
est concentration tested (30 ppm) (Abdo et al. 
1992), and in rats, the nasal olfactory epithe-
lium was a prominent target after 105 weeks 
of exposure (Abdo et al. 2001). Long et al. 
(2003) observed dose-dependent increases 
in adenomas of the respiratory epithelium 
and a significant increase in olfactory epithe-
lial neuro  blastomas in male and female rats, 
respectively. In the olfactory epithelium, the 
incidence of hyperplasia and chronic inflam-
mation was nearly 100%, even at the lowest 
concentration tested (10 ppm). Overall, the 
high degree of hyper  plastic and inflammatory 
effects and the relative susceptibility of areas 
of the nasal epithelium after long-term expo-
sures correlate well with the susceptible sites 
for acute toxicity (Lee et al. 2005) and raise 
the possibility that the tumori  genic effects of 
naphthalene observed in animals are related 
to repeated cycles of injury and repair (North 
et al. 2008).
The published assessments by regulatory 
bodies on the potential carcino  genicity of naph-
thalene in humans differ (e.g., International 
Agency for Research on Cancer 2002; National 
Toxicology Program 2004). Although the toxi-
cologic data in animals are very clear, human 
epidemiologic studies in populations of exposed 
workers are   uninformative. In most short-term 
mutagenicity assays, naphthalene is nega  tive 
(reviewed by Brusick 2008). Recent evidence 
for the formation of DNA adducts comes 
both from in vitro studies with naphthalene 
metabolites (Saeed et al. 2007) and from skin-
painting studies using both naphthalene and 
naphthalene metabolites (Saeed et al. 2009). 
The skin-painting studies demon  strated the 
presence of both depurinating and stable 
adducts, suggesting that this may be a possible 
mechanism for tumorigenesis associated with 
naphthalene in rodent models.
Previous studies demonstrating 10- to 
100-fold differences in the rates of pulmonary 
micro  somal formation of glutathione con-
jugates of naphthalene between rodents and 
human/nonhuman primates (Buckpitt et al. 
1992; Buckpitt and Bahnson 1986) and in 
dissected airways of rodents and non  human 
primates (Boland et al. 2004; Buckpitt et al. 
1995) suggested that humans would be consid-
erably less susceptible to naphthalene than are 
rodents. Although the dramatic differences in 
susceptibility to naphthalene of airway epithe-
lium in the mouse and rat appear to be related 
to metabolism of naphthalene by CYP2F, 
recent work showing that several human 
CYPs can metabolize naphthalene with high 
efficiency suggests that other CYP enzymes 
may catalyze the turnover of this substrate in 
humans (Cho et al. 2006; Fukami et al. 2008). 
In particular, CYP2A13, which has been 
reported in both lung and nasal epithelium of 
humans (for review, see Ding and Kaminsky 
2003), shows a Km of 36 µM and high catalytic 
efficiency with naphthalene. In addition, our 
finding of similar levels of covalent protein 
binding in nasal epithelium of the rodent and 
monkey (Figure 1), as well as observations that 
some (but not all) of the proteins adducted 
by reactive metabolites of naphthalene are the 
same in dissected airways and nasal epithelium 
of rodents and non  human primates (Lin et al. 
2005, 2006; see also Tables 1 and 2), supports 
the need for additional studies on the possible 
sensitivity of humans to naphthalene exposure. 
The concept that post  translational modi-
fication of proteins by electrophiles begins 
a series of events leading to cellu  lar necrosis 
was proposed by Brodie et al. (1971) some 
40 years ago, and was supported by studies 
showing correlations between overall electro-
phile protein adduct formation and toxicity 
(for a recent review, see Hanzlik et al. 2009). 
The advent of new MS techniques coupled 
with 2D gel electrophoresis has resulted in the 
identification of numerous protein targets for 
cytotoxic agents that require metabolic activa-
tion; a current database of these targets shows 
many commonalities (Fang et al. 2009). 
Despite these efforts, a final unifying hypothe-
sis tying the adduction of specific proteins 
with toxicity has not emerged, and additional 
work is needed to answer several questions. 
In those cases where adduction occurs to an 
abundant protein, is this protein simply act-
ing as a sink to trap electrophiles? Does the 
formation of an adduct with an individual 
protein alter the function of that protein 
directly, or is the dele  terious effect mediated 
by protein-interacting partners? These will 
clearly be challenging questions but, if solved, 
could greatly enhance our ability to more 
quickly and precisely assess the human risk 
of exposure to agents that undergo metabolic 
activation to protein-reactive electrophiles. 
As noted above, much of the progress 
in identifying proteins targeted by reactive 
metabolites has derived from the application 
of 2D gel electrophoresis and more rapid 
MS-based identifications. Although 2D gel 
electrophoresis arguably provides the great-
est resolving power for whole proteins of any 
separations technique available, there is still 
the potential of selecting a spot that con-
tains two unseparated proteins, one that is 
low abundance and adducted and one that 
is much higher abundance and identified by 
MS. Although we cannot exclude this as a 
possibility in the present study, we used IPG 
strips with very narrow ranges to lessen the 
potential for mis  identification. In only one 
case that we are aware of—with thiobenz-
amide—were the investigators able to show 
that the features removed from the gel were 
adducted by using isotope ratios with equal 
Figure 1. Covalent reactive metabolite binding to protein in rat, rhesus, and mouse tissue. Abbreviations: 
ethmo, ethmoturbinate; Maj D, major daughter; max, maxillo  turbinate; Min D, minor daughter. Fresh sam-
ples of rat septum (n = 3), rat olfactory ethmoturbinate (n = 3), rhesus maxillo  turbinate (n = 8), and rhesus 
ethmoturbinate (n = 8) were incubated with 14C-naphthalene (250 µM) for 2 hr at 37°C for determination of 
the levels of covalent reactive metabolite binding to protein. Values are mean ± SD. Reference values for 
tissue subcompartments of mouse lung are from Cho et al. (1994). 
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quantities of hydrogen/deuterium-labeled 
substrate (Ikehata et al. 2008). This was likely 
possible only because the adduct levels gener-
ated from thiobenzamide are considerably 
greater than those for other metabolically acti-
vated toxicants.
In the present study, adducts with the 
structural proteins actin and tubulin were iso-
lated from both rat and monkey nasal epithe-
lial incubations. These are high-abundance 
proteins in the cell that have been identified 
in several other studies as common targets for 
other reactive metabolites, including butylated   
hydroxy  toluene (BHT) (Meier et al. 2005), 
benzene (Williams et al. 2002), thio-
benzamide (Ikehata et al. 2008), and the 
model thiol-reactive electrophiles biotinyl-
iodo  acetamidyl-3,6-dioxaoctane  diamine and 
1-biotinamido-4-(4´[maleidoethylcyclohexane]-
carboxyamido)butane (Dennehy et al. 2006). 
The formation of covalent adducts with actin 
and tubulin is not generally considered to be 
a critical step in the pathway to cellular injury 
because the specific activity of these adducted 
proteins (nanomoles bound per nanomole of 
protein) is likely to be quite low. However, 
one of the earliest signs of cellular disruption 
in naphthalene-treated mice involves the for-
mation of apical membrane blebs and appar-
ent disruption of cytoplasmic filaments (Van 
Winkle et al. 1999). Similar signs of disrup-
tion of cyto  skeletal elements have been noted 
in airway epithelial cells after adminis  tration of 
diethyl maleate, but these changes resolved and 
did not lead to frank necrosis (Phimister et al. 
2005). This is consistent with previous work 
Table 1. Adducted proteins identified from incubation of rat olfactory ethmoturbinate with 14C-naphthalene.
Gel 
spot
Protein name 
(  abbreviated)
MOWSE 
scorea
Peptide 
countb
Protein score 
CI%c Accession no.d
Protein 
MW (Da)
Protein 
pI Summary of function
N1 Sorcin (P30626) 133 5 100 SORCN CRILOe  22017.4 5.32 Calcium-binding protein 
N4 Golgi autoantigen 90 24 99.951 GI: 808869f  372014.8 4.96 May participate in forming intercisternal 
cross bridges of the Golgi complex
N7 pyruvate dehydrogenase 69 7 99.596 ODPB_RATe  39,336 5.94 Glycolysis
N8 mu-crystallin 135 4 100 IPI00214448  33704.1 5.34 Ammonia elimination
N9 pyrophosphatase 67 7 99.283 IPI00371957 33206.3 5.26 Signal transduction
N12 creatinine kinase 543 20 100 IPI00470288 42983.4 5.39 Energy transduction
N13 Sec 1413 protein 131 6 100 IPI00208939 46453.5 5.64 Hydrophobic ligand binding
N19 creatinine kinase 299 10 100 IPI00470288 42983.4 5.39 Energy transduction
N23 actin 259 10 100 IPI00369618 59162.6 5.67 Structural
N24 eukaryotic translation 
initiation factor 4A1
129 14 100 IPI00369618 46352.6 5.32 Protein synthesis initiation
N25 beta actin 447 10 100 GI: 62897625f  41737.8 5.37 Structural
N26 actin, cytoplasmic 420 15 100 IPI00767505 42108.9 5.31 Structural
N27 actin 753 17 100 IPI00194087 42,334 5.23 Structural
N29 actin, cytoplasmic 198 6 100 IPI00765011 59162.6 5.67 Structural
N32 actin, cytoplasmic 167 4 100 IPI00765011 59162.6 5.67 Structural
N33 actin, cytoplasmic 186 5 100 IPI00765011 59162.6 5.67 Structural
N41 ATP synthase 919 21 100 IPI00551812 56318.5 5.19 ATP catabolism
N43 ATP synthase 160 17 100 IPI00551812 56318.5 5.19 ATP catabolism
N47 heat shock protein 1A 
(chaperonin) (Hsp 60)
220 27 100 IPI00339148 61088.4 5.91 Stress-induced chaperone; protein 
folding
N51 heat shock 70 kDa 9 A 
(predicted)
419 9 100 IPI00363265 74,097 5.97 Protein folding; protein export; binds 
ATP, nucleotides, and proteins
N53 heat shock 70 kDa 9 A 
(predicted)
64 5 98.428 IPI00858386 74098.9 5.97 Protein folding; protein export; binds 
ATP, nucleotides, and proteins 
N55 Vomeromodulin 87 8 99.992 IPI00209782 79527.3 5.92 Putative pheromone and odorant 
transporter
N56 heat shock 70 kDa, 
protein 5
621 15 100 IPI00206624 72473.5 5.07 Assembly of multimeric protein 
complexes 
N57 heat shock 70 kDa, 
protein 5
896 27 100 IPI00206624 72473.5 5.07 Assembly of multimeric protein 
complexes 
N61 tyrosine 3-mono-
oxygenase Tryptophan 5
243 12 100 IPI00230835 28,456 4.8 Adapter protein; signal transduction
N63 tubulin 485 12 100 IPI00189795 50787.9 4.94 Structural
N64 tubulin 174 16 100 IPI00339167 50119.6 4.94 Structural
N65 tubulin 148 14 100 IPI00339167 50119.6 4.94 Structural
N66 tubulin  258 23 100 IPI00400573 49,769 4.79 Structural
N67 tubulin 464 24 100 IPI00197579 49,639 4.78 Structural
N68 protein disulfide 
isomerase
272 17 100 IPI00198887 56915.7 4.82 Cell redox homeostasis
N69 protein disulfide 
isomerase
139 15 100 IPI00198887 56915.7 4.82 Cell redox homeostasis 
N70 protein disulfide 
isomerase
227 25 100 IPI00198887 56915.7 4.82 Cell redox homeostasis 
N73 ubiquinol-cytochrome c 
reductase core protein 1
162 16 100 IPI00471577 57815.4 5.57 Mitochondrial electron transport
N74 ubiquinol-cytochrome c 
reductase core protein 1
78 19 99.939 IPI00471577 52815.4 5.57 Mitochondrial electron transport 
N75 chloride intracellular 
channel 1
212 14 100 IPI00421995 26963.8 5.09 Macrophage activation
N76 tubulin 166 12 100 IPI0018975 5103.6 4.94 Structural
N77 tubulin 126 19 100 IPI00400573 49,769 4.79 Structural
aThe probability-based MOWSE score from MASCOT. bPeptides used for matching within the database. cReflects the probability that this same match would be made in a different 
database. dAccession numbers are from the IPI rat database except where noted. eFrom the Swiss-Prot database searching mammals. fFrom the NCBI database searching mammals.Reactive naphthalene metabolites in nasal tissue
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showing that S-glutathionylation of cysteine-
374 of actin reduces the rate of polymeriza-
tion of this structural molecule (Dalle-Donne 
et al. 2003) and that glutathionylation of this 
protein leads to decreased affinity of its partner 
protein tropo  myosin (Chen and Ogut 2006). 
Both naphthalene and diethyl maleate sub-
stantially deplete gluta  thione levels in airway 
epithelium, which may result in increased lev-
els of glutathionylated actin. Reactive metabo-
lites from naphthalene produce a double hit 
on actin and tropo  myosin, resulting in both 
thiolation reactions (which are reversible) and 
covalent arylation reactions (which presum-
ably are not). Ongoing work in our labora-
tory is evaluating the protein targets of diethyl 
maleate as a mechanism for distinguishing 
adducts that may be critical to cellular injury 
from those that are not.
We observed a potentially important 
group of protein targets in nasal olfactory 
epithelial incubations from the rat but not 
from the monkey; these proteins are respon-
sible for protein folding and repair in the 
cell. Glutathione depletion is a necessary but 
insufficient prelude to naphthalene cyto-
toxicity. The loss of this key thiol leaves the 
cell vulnerable to intra  cellular reactive oxy-
gen species that, with diethyl maleate, can 
be corrected by chaperones, protein disulfide 
isomerase, peroxi  redoxins, and possibly sev-
eral other proteins involved in anti  oxidant 
protection and protein folding. With naph-
thalene, several of these proteins, includ-
ing the master regulator of the unfolded 
protein response, BiP/GRP78 (78 kDa glucose- 
regulated protein) (Townsend 2007), as well 
as the heat shock proteins HSP60 and HSP70, 
are adducted, thus potentially altering their 
ability to repair proteins under  going thiol oxi-
dation and unfolding during the early stages 
of naphthalene toxicity. This is consistent with 
findings showing marked up-regulation of 
the HSPs in mouse lung at early times after 
naphthalene treatment (Williams et al. 2003). 
An interesting but unproven link in possible 
mechanisms comes from recent work demon-
strating that proteins involved in the unfolded 
protein response are substantially up-regulated 
in smokers compared with former smokers 
and non  smokers (Kelsen et al. 2008).
The present study provides a list of poten-
tial protein targets and shows that some of 
these are similar in nasal epithelium of the 
rat (a known target for naphthalene toxicity) 
and that of the rhesus macaque. We derived 
several other adducted proteins from monkey 
nasal epithelial incubations, but these yielded 
unreliable identifications. We are working 
on methods for concentrating adducted pro-
teins to provide greater sensitivity for these 
analyses. In the future, it will be important to 
gain additional insight regarding critical ver-
sus non  critical protein adduction. Part of this 
information will come from studies such as 
that published by Meier et al. (2007), which 
showed that metabolites of BHT alkylate key 
anti  oxidant enzymes and that the alkylation 
resulted in a decrement in enzyme function 
that, in turn, was consistent with the biologi-
cal responses after BHT treatment.
In the present study we focused on pro-
tein adducts that are most likely related to 
acute cellular injury. Whether repeated cycles 
of injury and repair with subsequent hyper-
plasia are related to naphthalene tumori-
genicity will need additional study. Finally, 
the possibility that exposure to naphthalene 
and other similar, volatile polycyclic aromatic 
hydrocarbons (PAHs) could produce lung dis-
ease other than cancer should be explored. 
In this regard, limited studies have reported 
correlations between serum levels of naph-
thalene and pyrene, but not other PAHs, 
with asthma incidence in children (Al-Daghri 
2008). Moreover, there is a clear association 
of exposure to traffic-related pollution and 
asthma (Kim et al. 2005), and naphthalene is 
the most prevalent PAH in this mixture (Lu 
et al. 2005). Recent work showing that poly-
morphisms that result in alterations in enzy-
matic activities for two key enzymes involved 
in the metabolism of PAHs (microsomal epox-
ide hydrolase and glutathione transferase pi) 
lead to increased incidence of asthma in chil-
dren living near freeways (Salam et al. 2007) 
provide an interesting but unsubstantiated 
link between PAHs in motor vehicle exhaust 
and asthma. The understanding of target pro-
teins and their relationship to the pathology 
from naphthalene in animals should improve 
our ability to assess the possible risks of this 
compound in exposed human populations.
Conclusion
This study shows that the amounts of covalent 
adduct generated from naphthalene in incuba-
tions of rhesus nasal epithelium are similar to 
those formed using rat olfactory and septal 
nasal epithelium, two sites known to be sus-
ceptible to the cytotoxicity associated with 
naphthalene. Many of the adducted proteins 
identified are the same as those observed in 
incubations with other target tissues. Our 
results are consistent with the view that nasal 
epithelium of the rhesus macaque may be sus-
ceptible to naphthalene cytotoxicity.
Table 2. Adducted proteins identified from incubations of monkey ethmoturbinate with 14C-naphthalene.
Gel spot
Protein name 
(abbreviated)
MOWSE 
scorea
Peptide 
countb
Protein 
score CIc Accession no.d
Protein 
MW (Da) Protein pI Function 
M1 actin 333 22 100 P60709 40978.4 5.56 Structural
M2 actin 628 25 100 GI: 62897625 41737.8 5.37 Structural
M3 actin 526 23 100 P60709 40978.4 5.56 Structural
M4 tubulin 95 17 99.992 GI: 114627728 7398.9 4.72 Structural
M5 actin 107 11 100 P68133 37799.8 5.39 Structural
M6 actin 469 18 100 Q8WvW5 40477.2 5.78 Structural
M7 actin 690 23 100 GI: 4501883 41981.8 5.23 Structural
M8 actin 479 20 100 GI: 4501883 41981.8 5.23 Structural
M9 actin 181 13 100 GI: 4885049 41981.9 5.23 Structural
M10 actin 147 10 100 GI: 149758067 37799.8 5.39 Structural
M11 fibrinogen 162 12 100 GI: 109075971 36492.6 5.61 Various
M12 protease inhibitor 514 22 100 GI: 109084715 46669.9 5.55 Various
M13 actin 528 23 100 GI: 15277503 40194.1 5.55 Structural
M14 actin 588 26 100 GI: 62897671 41693.7 5.29 Structural
M15 tubulin 455 25 100 GI: 18088719 49639.9 4.75 Structural
M16 tubulin 253 20 100 GI: 23958133 49808 4.83 Structural
M17 actin 226 15 100 GI: 14250401 40978.9 5.56 Structural
M18 tubulin 338 20 100 GI: 114627728 47398.9 4.72 Structural
M19 actin 491 19 100 GI: 4885049 41991.9 5.23 Structural
M20 tubulin 314 15 100 GI: 109096498 42214.1 4.94 Structural
M21 protease inhibitor 106 11 100 GI: 109069435 42214.1 5.08 Various
aThe probability-based MOWSE score from MASCOT. bPeptides used for matching within the database. cReflects the probability that this same match would be made in a different 
database. dFrom the NCBI database searching mammals.DeStefano-Shields et al.
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In Tables 1 and 2 of the manuscript origi-
nally published online, information for 
seve  ral proteins was incorrect. The tables 
have been corrected here.
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